MN Services Vermogensbeheer’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Hold |
35,500
| – | – | 0.01% | 458 |
|
2025
Q1 | $2.51M | Buy |
35,500
+3,800
| +12% | +$269K | 0.02% | 438 |
|
2024
Q4 | $2.08M | Hold |
31,700
| – | – | 0.01% | 461 |
|
2024
Q3 | $2.23M | Hold |
31,700
| – | – | 0.02% | 463 |
|
2024
Q2 | $2.61M | Hold |
31,700
| – | – | 0.02% | 455 |
|
2024
Q1 | $2.77M | Sell |
31,700
-54,400
| -63% | -$4.75M | 0.02% | 462 |
|
2023
Q4 | $8.3M | Sell |
86,100
-3,300
| -4% | -$318K | 0.07% | 279 |
|
2023
Q3 | $7.91M | Hold |
89,400
| – | – | 0.08% | 275 |
|
2023
Q2 | $7.75M | Buy |
+89,400
| New | +$7.75M | 0.07% | 291 |
|
2019
Q3 | – | Sell |
-30,631
| Closed | -$2.62M | – | 381 |
|
2019
Q2 | $2.62M | Hold |
30,631
| – | – | 0.03% | 475 |
|
2019
Q1 | $2.72M | Buy |
30,631
+500
| +2% | +$44.4K | 0.03% | 446 |
|
2018
Q4 | $2.24M | Buy |
30,131
+2,300
| +8% | +$171K | 0.03% | 435 |
|
2018
Q3 | $2.7M | Hold |
27,831
| – | – | 0.06% | 326 |
|
2018
Q2 | $2.62M | Sell |
27,831
-1,200
| -4% | -$113K | 0.07% | 325 |
|
2018
Q1 | $2.35M | Buy |
29,031
+1,900
| +7% | +$154K | 0.06% | 345 |
|
2017
Q4 | $2.02M | Sell |
27,131
-1,500
| -5% | -$111K | 0.06% | 327 |
|
2017
Q3 | $2.67M | Hold |
28,631
| – | – | 0.07% | 303 |
|
2017
Q2 | $2.6M | Buy |
28,631
+24,044
| +524% | +$2.18M | 0.07% | 305 |
|
2017
Q1 | $376K | Buy |
4,587
+166
| +4% | +$13.6K | 0.07% | 295 |
|
2016
Q4 | $347K | Buy |
4,421
+260
| +6% | +$20.4K | 0.07% | 300 |
|
2016
Q3 | $385K | Buy |
4,161
+79
| +2% | +$7.31K | 0.08% | 285 |
|
2016
Q2 | $286K | Buy |
4,082
+90
| +2% | +$6.31K | 0.07% | 322 |
|
2016
Q1 | $289K | Buy |
+3,992
| New | +$289K | 0.07% | 322 |
|